Skip to main content

Abbott: US baby formula plant linked to national shortage resumes production

 

Abbott: US baby formula plant linked to national shortage resumes production


US firm Abbott says it is restarting production at a baby formula plant after its shutdown contributed to a national shortage of the baby food.

The plant in Michigan - one of America's largest - was closed in February because of contamination.

Coupled with global supply chain issues, the factory's closure led to acute shortages.

Parents were left scrambling for supplies, seeking formula from food banks, friends and doctor's offices.

Some turned to social media to try to track down baby milk, while others attempted to make their own substitutes (against medical advice).

The facility has met initial government sanitary requirements for reopening, the company said in a statement.

Abbott said it would initially prioritise the production of its EleCare speciality formulas for babies with severe food allergies and digestive problems.

"We're also working hard to fulfil the steps necessary to restart production of Similac and other formulas," Abbott said, referring to its more mainstream products. It plans to ramp up production as quickly as possible "while meeting all requirements", it said.

The company said it would take about three weeks before new formula from the plant began reaching stores.

Baby formula producer to supply US amid shortage
Online groups hunt for baby formula during US shortage
US mothers warned against DIY formula amid shortage
Last month, US President Joe Biden invoked the Defense Production Act, a war-time measure, to boost domestic production of formula, and ordered the Pentagon to fly in shipments from overseas.

A bill to alleviate the shortage was also overwhelmingly passed by the House of Representatives.

Other countries have supplied formula to boost supplies during the crisis.

The Abbott plant shut down in February after the death of two babies, and the company issued a product recall amid concerns over bacterial contamination.

Inspectors for the Food and Drug Administration (FDA) say they uncovered a number of anomalies at the plant, including bacterial contamination, leaks in the roof and a lack of basic hygiene.

The company says there is no conclusive evidence linking its products to infant illnesses or deaths.

Comments

Popular posts from this blog

Migrant caravan heads to US as key summit begins

  Migrant caravan heads to US as key summit begins Thousands of migrants are headed to the US-Mexican border in a caravan timed to coincide with a meeting of Western Hemisphere leaders in Los Angeles. Some 6,000 people, including many from Venezuela and Central America, have begun walking from the southern tip of Mexico north as part of a caravan. Migration is among the top issues on the agenda at the Summit of the Americas. The caravan may be one of the largest in recent years. On Monday, the group began its 1,270 mile (2,000 km) journey to the US from the Mexican city of Tapachula, near the country's border with Guatemala. It is unclear when they will arrive at the northern frontier. The group's organisers say it is made up of people who are fleeing instability, violence and poverty in their home countries. Robinson Reyes, 35, a Colombian migrant, said he was traveling north after waiting in vain in Mexico for a month for a humanitarian visa. "We want a future for our fa...

Democratic frontrunners Rick Caruso, Karen Bass advance to November runoff in LA mayor race

  Democratic frontrunners Rick Caruso, Karen Bass advance to November runoff in LA mayor race LOS ANGELES — The race for Los Angeles mayor will head to a November runoff after no candidate secured at least 50% of the vote in Tuesday's primary. Both Democratic frontrunners – Rep. Karen Bass and billionaire developer Rick Caruso – will move forward.  As of 10 p.m. PDT, Caruso held a 3-point lead over Bass, a win in itself against an established Los Angeles politician who was on President Joe Biden's short list for vice president.  Both candidates will appear on the November ballot for the general election, where voters will also be tasked with deciding on a number of other races, including governor, Senate and House seats. The race could mark a turning point for the city, which boasts the second largest population in the country, and put its reputation as a progressive trendsetter at risk.  The winner will take over for Eric Garcetti, who was nominated to be the U.S. a...